
Albireo Pharma ALBO
Albireo Pharma Total Non Current Liabilities | ALBO
Annual Total Non Current Liabilities Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 79.1 M | 53 M | 50 M | 42 K | 359 K | 59 K | 1.01 M | 6.15 M | 7.34 M | 1.14 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.1 M | 42 K | 19.8 M |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
bluebird bio
BLUE
|
170 M | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
276 K | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
12.3 M | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
9.41 M | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
31.9 M | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
274 K | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
9.97 M | - | - | $ 127 M | ||
|
Aravive
ARAV
|
10.2 M | - | -13.39 % | $ 1.45 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
4.9 M | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
244 K | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
29.2 B | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
2.06 M | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
218 M | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
2.42 M | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
12 M | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
807 K | - | - | $ 58.1 M | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
24.8 M | - | -14.27 % | $ 1.7 M | ||
|
Adverum Biotechnologies
ADVM
|
27.3 M | - | - | $ 86.2 M | ||
|
BELLUS Health
BLU
|
932 K | - | - | $ 2.47 B | ||
|
Intra-Cellular Therapies
ITCI
|
20 M | - | - | $ 13.6 B | ||
|
Marinus Pharmaceuticals
MRNS
|
2.53 M | - | - | $ 29.6 M | ||
|
GeoVax Labs
GOVX
|
170 K | $ 1.83 | -4.45 % | $ 8.35 M | ||
|
Unity Biotechnology
UBX
|
13.3 M | - | -33.41 % | $ 3.37 M | ||
|
Applied Molecular Transport
AMTI
|
106 M | - | - | $ 10.1 M | ||
|
Tyme Technologies
TYME
|
546 K | - | 8.07 % | $ 54 M | ||
|
Karuna Therapeutics
KRTX
|
13.8 M | - | - | $ 12.2 B | ||
|
Revance Therapeutics
RVNC
|
541 M | - | - | $ 309 M | ||
|
Aptinyx
APTX
|
114 K | - | -39.0 % | $ 4.57 M | ||
|
TRACON Pharmaceuticals
TCON
|
3.59 M | - | -1.38 % | $ 46.8 M | ||
|
Forward Pharma A/S
FWP
|
43 K | - | -0.75 % | $ 18.7 M | ||
|
Theratechnologies
THTX
|
41.8 M | - | - | $ 83.9 M | ||
|
Allena Pharmaceuticals
ALNA
|
10.2 M | - | 3.16 % | $ 1.9 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
170 M | - | -15.15 % | $ 60.3 M | ||
|
TFF Pharmaceuticals
TFFP
|
1.13 M | - | -60.05 % | $ 125 K | ||
|
Codiak BioSciences
CDAK
|
91 M | - | -55.98 % | $ 2.15 M | ||
|
Sage Therapeutics
SAGE
|
10.5 M | - | - | $ 527 M | ||
|
Paratek Pharmaceuticals
PRTK
|
255 M | - | - | $ 121 M | ||
|
AVEO Pharmaceuticals
AVEO
|
40.7 M | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
38.9 M | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
7.49 M | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
89.5 M | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
228 K | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
15.9 M | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
4.31 M | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
30.5 M | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
854 K | - | 17.91 % | $ 11.1 M |